Skip to main content

Table 1 Adult patient characteristics at enrollment into HIV Care, by enrollment year

From: Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study

 

Total

2006-2007

2008-2009

2010-2011

p-value1

 

n = 93,418

%2

n = 34,528

%2

n = 35,242

%2

n = 23,648

%2

Age category

        

<0.0001

15-24 yrs

14,997

16.1

5,361

15.5

5,687

16.1

3,949

16.7

 

25-39 yrs

57,160

61.2

21,519

62.3

21,532

61.1

14,109

59.7

 

40-49 yrs

14,675

15.7

5,490

15.9

5,438

15.4

3,747

15.8

 

50+ yrs

6,586

7.1

2,158

6.3

2,585

7.3

1,843

7.8

 

Sex

        

0.0002

Male

36,906

39.5

13,917

40.3

13,857

39.3

9,132

38.6

 

Female

56,512

60.5

20,611

59.7

21,385

60.7

14,516

61.4

 

Religion

        

<0.0001

Orthodox

56,616

60.6

21,398

62.0

21,260

60.3

13,958

59.0

 

Muslim

16,145

17.3

5,142

14.9

6,157

17.5

4,846

20.5

 

Protestant

14,205

15.2

5,538

16.0

5,358

15.2

3,309

14.0

 

Other/Unknown

6,452

6.9

2,450

6.8

2,467

6.6

1,535

6.1

 

Marital status

        

<0.0001

Never Married

12,591

13.5

4,828

14.0

4,520

12.8

3,243

13.7

 

Married/Living together

48,218

51.6

16,780

48.6

18,653

52.9

12,785

54.1

 

Separated/Divorced

16,971

18.2

6,360

18.4

6,289

17.9

4,322

18.3

 

Widowed

11,165

12.0

4,633

13.4

3,996

11.3

2,536

10.7

 

Other/Unknown

4,473

4.8

1,927

5.6

1,784

5.1

762

3.2

 

Education

        

<0.0001

No Education

27,547

29.5

9,309

27.0

10,697

30.4

7,541

31.9

 

Primary

34,178

36.6

12,768

37.0

12,794

36.3

8,616

36.4

 

Secondary

20,943

22.4

8,667

25.1

7,603

21.6

4,673

19.8

 

Tertiary

5,565

6.0

1,606

4.7

2,118

6.0

1,841

7.8

 

Other/Unknown

5,185

5.6

2,178

6.3

2,030

5.8

977

4.1

 

Point of entry into care

       

<0.0001

PITC

34,566

37.0

9,538

27.6

14,425

40.9

10,603

44.8

 

VCT

29,128

31.2

13,162

38.1

9,713

27.6

6,253

26.4

 

Other Hospital/HC

12,930

13.8

6,418

18.6

4,142

11.8

2,370

10.0

 

Community

1,143

1.2

483

1.4

370

1.0

290

1.2

 

Unknown/missing

15,651

16.8

4,927

14.3

6,592

18.7

4,132

17.5

 

Transferred in

1,607

1.7

526

1.5

535

1.5

546

2.3

<0.0001

WHO Stage

        

<0.0001

Stage I

23,979

26

6,891

20

9,767

28

7,321

31

 

Stage II

16,595

18

5,272

15

6,655

19

4,668

20

 

Stage III

33,072

35

13,299

39

12,023

34

7,750

33

 

Stage IV

6,456

7

3,395

10

1,800

5

1,261

5

 

Missing

13,316

14

5,671

16

4,997

14

2,648

11

 

CD4+ cell count (cells/mm3)

       

Median(IQR)

183 (87–342)

158 (76–293)

195 (93–360)

208 (98–376)

<0.0001

<100

19,392

21

8,017

23

6,814

19

4,561

19

 

100-199

16,818

18

6,557

19

6,087

17

4,174

18

 

200-350

15,077

16

5,006

14

5,809

16

4,262

18

 

350+

16,364

18

4,612

13

6,650

19

5,102

22

 

Missing

25,767

28

10,336

30

9,882

28

5,549

23

 

TB screening at enrollment

       

<0.0001

Yes

54,033

57.8

11,275

32.7

23,505

66.7

19,253

81.4

 

No/not recorded

39,385

42.2

23,253

67.3

11,737

33.3

4,395

18.6

 

TB treatment at enrollment

       

<0.0001

Yes

8,445

9.0

3,091

9.0

2,969

8.4

2,385

10.1

 

No/not recorded

84,973

91.0

31,437

91.0

32,273

91.6

21,263

89.9

 

Cotrimoxazole at enrollment

       

<0.0001

Yes

59,652

63.9

20,032

58.0

22,870

64.9

16,750

70.8

 

No/not recorded

33,766

36.1

14,496

42.0

12,372

35.1

6,898

29.2

 

Facility type

        

<0.0001

Primary (11 sites)

4,844

5.2

1,316

3.8

1,934

5.5

1,594

6.7

 

Secondary/tertiary (45 sites)

88,574

94.8

33,212

96.2

33,308

94.5

22,054

93.3

 

Setting

        

<0.0001

Urban city (25 sites)

57,904

62.0

22,693

65.7

21,408

60.7

13,803

58.4

 

Semi-urban (21 sites)

29,219

31.3

10,492

30.4

11,442

32.5

7,285

30.8

 

Rural (10 sites)

6,295

6.7

1,343

3.9

2,392

6.8

2,560

10.8

 

Initiated ART

         

Yes

53,300

57.1

21,920

63.5

19,296

54.8

12,084

51.1

<0.0001

No

40,118

42.9

12,608

36.5

15,946

45.2

11,564

48.9

 
  1. 1p-values based on chi-squared test for any difference across groups over time. see text for specific tests for trend.
  2. 2categorical percentages may not total exactly 100% due to roundoff errors.